UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Magnetotransport properties of high-quality cobalt nanowires grown by focused-electron-beam-induced deposition

Journal of physics. D, Applied physics, 2009-03, Vol.42 (5), p.055005-055005 (6)

2009

Volltextzugriff (PDF)

Adaptation of a scale to measure coping strategies in informal primary caregivers of psychiatric patients

Journal of psychiatric and mental health nursing, 2017-10, Vol.24 (8), p.563-569

2017

Volltextzugriff (PDF)

Stigma and functioning in patients with bipolar disorder

Journal of affective disorders, 2011-04, Vol.130 (1), p.323-327

2011

Volltextzugriff (PDF)

Microscopic model for all optical switching in ferromagnets

Applied physics letters, 2016-04, Vol.108 (14)

2016

Volltextzugriff (PDF)

HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R‐CHOP IN PREVIOUSLY UNTREATED (1L) HIGH‐RISK DLBCL, INCLUDING DOUBLE‐HIT/TRIPLE‐HIT: EPCORE NHL‐2 UPDATE

Hematological oncology, 2023-06, Vol.41 (S2), p.207-208

2023

Volltextzugriff (PDF)

High-purity cobalt nanostructures grown by focused-electron-beam-induced deposition at low current

Microelectronic engineering, 2010-05, Vol.87 (5), p.1550-1553

2010

Volltextzugriff (PDF)

Enhancement of long-range correlations in a 2D vortex lattice by an incommensurate 1D disorder potential

Nature physics, 2014-11, Vol.10 (11), p.851-856

2014

Volltextzugriff (PDF)

OPEN‐LABEL PHASE 1/2 STUDY OF CC‐99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT ± RITUXIMAB, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL)

Hematological oncology, 2023-06, Vol.41 (S2), p.134-136

2023

Volltextzugriff (PDF)

GLOFITAMAB PLUS POLATUZUMAB VEDOTIN DEMONSTRATES DURABLE RESPONSES AND A MANAGEABLE SAFETY PROFILE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

Hematological oncology, 2023-06, Vol.41 (S2), p.138-140

2023

Volltextzugriff (PDF)

A phase II, open‐label, multicenter study of capivasertib, a potent, oral pan‐AKT inhibitor, in patients with relapsed or refractory B‐cell non‐Hodgkin lymphoma (CAPITAL)

Hematological oncology, 2023-06, Vol.41 (S2), p.562-564

2023

Volltextzugriff (PDF)

Cancer and aging in Ibero-America

Clinical & translational oncology, 2018-09, Vol.20 (9), p.1117-1126

2018

Volltextzugriff (PDF)

Individual vocal recognition and dear enemy effect in the black-and-gold howler monkey (Alouatta caraya)

Behavioral ecology and sociobiology, 2024-04, Vol.78 (4), p.51, Article 51

2024

Volltextzugriff (PDF)

PHASE 1/2A CLINICAL TRIAL OF BI‐1206, A MONOCLONAL ANTIBODY TO CD32B (FCGRIIB), IN COMBINATION WITH RITUXIMAB IN SUBJECTS WITH INDOLENT B‐CELL LYMPHOMA

Hematological oncology, 2023-06, Vol.41 (S2), p.835-836

2023

Volltextzugriff (PDF)

Topic identification techniques applied to dynamic language model adaptation for automatic speech recognition

Expert systems with applications, 2015-01, Vol.42 (1), p.101-112

2015

Volltextzugriff (PDF)

Comparison Between aaIPI, LAB‐PI, NCCN‐IPI and GELTAMO‐IPI to Predict Prognosis in Elderly Patients with Diffuse Large‐B Cell Lymphoma who Undergo R‐CHOP/R‐miniCHOP

Hematological oncology, 2023-06, Vol.41 (S2), p.413-414

2023

Volltextzugriff (PDF)

Review of magnetic nanostructures grown by focused electron beam induced deposition (FEBID)

Journal of physics. D, Applied physics, 2016-06, Vol.49 (24), p.243003

2016

Volltextzugriff (PDF)

P1104: A PHASE 1 STUDY EVALUATING SAFETY AND EFFICACY OF PARSACLISIB IN COMBINATION WITH BENDAMUSTINE + OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (CITADEL‐102)

HemaSphere, 2022-06, Vol.6 (Suppl), p.994-995

2022

Volltextzugriff (PDF)

P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT

HemaSphere, 2022-06, Vol.6 (Suppl), p.1099-1100

2022

Volltextzugriff (PDF)

P1214: SUBCUTANEOUS EPCORITAMAB + R‐CHOP FOR FIRST‐LINE TREATMENT OF PATIENTS WITH HIGH‐RISK DIFFUSE LARGE B‐CELL LYMPHOMA: PHASE 1/2 UPDATE

HemaSphere, 2022-06, Vol.6 (Suppl), p.1100-1101

2022

Volltextzugriff (PDF)

Direct observation of melting in a two-dimensional superconducting vortex lattice

Nature physics, 2009-09, Vol.5 (9), p.651-655

2009

Volltextzugriff (PDF)

CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH R‐CHOP: STUDY OF THE SPANISH LYMPHOMA GROUP GELTAMO

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

Fabrication of cobalt trifluoride (CoF3) phase from metallic cobalt by XeF2-assisted Focused Electron Beam Induced Processing

Microelectronic engineering, 2014-08, Vol.125, p.78-82

2014

Volltextzugriff (PDF)

Design, development and field evaluation of a Spanish into sign language translation system

Pattern analysis and applications : PAA, 2012-05, Vol.15 (2), p.203-224

2012

Volltextzugriff (PDF)

P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R‐DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT

HemaSphere, 2022-06, Vol.6 (Suppl), p.1101-1102

2022

Volltextzugriff (PDF)

1 – 25 von 2.121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.812)
Mit Volltextzugriff
(1.738)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.087)
Life Sciences & Biomedicine
(750)
Humans
(498)
Female
(310)
Male
(277)
Biological And Medical Sciences
(259)
Physical Sciences
(256)
Middle Aged
(175)
Technology
(162)
Adult
(153)
Animals
(147)
Fundamental And Applied Biological Sciences. Psychology
(142)
Aged
(134)
Medical Sciences
(124)
Chemistry
(106)
Spain
(105)
Exact Sciences And Technology
(97)
Physics
(92)
Agriculture
(82)
Plant Sciences
(72)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(20)
... seit 30 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Magnetotransport properties of high-quality cobalt nanowires grown by focused-electron-beam-induced deposition

Adaptation of a scale to measure coping strategies in informal primary caregivers of psychiatric patients

Stigma and functioning in patients with bipolar disorder

Microscopic model for all optical switching in ferromagnets

HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R‐CHOP IN PREVIOUSLY UNTREATED (1L) HIGH‐RISK DLBCL, INCLUDING DOUBLE‐HIT/TRIPLE‐HIT: EPCORE NHL‐2 UPDATE

High-purity cobalt nanostructures grown by focused-electron-beam-induced deposition at low current

Enhancement of long-range correlations in a 2D vortex lattice by an incommensurate 1D disorder potential

OPEN‐LABEL PHASE 1/2 STUDY OF CC‐99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT ± RITUXIMAB, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL)

GLOFITAMAB PLUS POLATUZUMAB VEDOTIN DEMONSTRATES DURABLE RESPONSES AND A MANAGEABLE SAFETY PROFILE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

A phase II, open‐label, multicenter study of capivasertib, a potent, oral pan‐AKT inhibitor, in patients with relapsed or refractory B‐cell non‐Hodgkin lymphoma (CAPITAL)

Cancer and aging in Ibero-America

Individual vocal recognition and dear enemy effect in the black-and-gold howler monkey (Alouatta caraya)

PHASE 1/2A CLINICAL TRIAL OF BI‐1206, A MONOCLONAL ANTIBODY TO CD32B (FCGRIIB), IN COMBINATION WITH RITUXIMAB IN SUBJECTS WITH INDOLENT B‐CELL LYMPHOMA

Topic identification techniques applied to dynamic language model adaptation for automatic speech recognition

Comparison Between aaIPI, LAB‐PI, NCCN‐IPI and GELTAMO‐IPI to Predict Prognosis in Elderly Patients with Diffuse Large‐B Cell Lymphoma who Undergo R‐CHOP/R‐miniCHOP

Review of magnetic nanostructures grown by focused electron beam induced deposition (FEBID)

P1104: A PHASE 1 STUDY EVALUATING SAFETY AND EFFICACY OF PARSACLISIB IN COMBINATION WITH BENDAMUSTINE + OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (CITADEL‐102)

P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT

P1214: SUBCUTANEOUS EPCORITAMAB + R‐CHOP FOR FIRST‐LINE TREATMENT OF PATIENTS WITH HIGH‐RISK DIFFUSE LARGE B‐CELL LYMPHOMA: PHASE 1/2 UPDATE

Direct observation of melting in a two-dimensional superconducting vortex lattice

CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH R‐CHOP: STUDY OF THE SPANISH LYMPHOMA GROUP GELTAMO

Fabrication of cobalt trifluoride (CoF3) phase from metallic cobalt by XeF2-assisted Focused Electron Beam Induced Processing

Design, development and field evaluation of a Spanish into sign language translation system

P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R‐DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT

Suchergebnisse filtern